Speaker Profile
Ph.D., Director, Eli Lilly &
Biography
Melody Shahsavarian, Ph.D., is Senior Director of Data Strategy and Digital Transformation in Biotherapeutics Discovery Research at Eli Lilly and Company. She leads efforts to make experimental data, automation, and artificial intelligence more accessible and useful across biologics discovery. Her career has combined wet-lab science with technology-platform development, including phage-display antibody libraries, droplet microfluidics, next-generation sequencing, immune-repertoire profiling, and data systems designed to support machine learning. Before joining Lilly, she spent nearly nine years at Sanofi Large Molecules Research and predecessor organizations, progressing through scientific leadership roles focused on biologics and digital innovation. Dr. Shahsavarian earned a B.S. in Bioengineering from the University of California, San Diego, an M.S. in Biotechnology and Biomedicine from Université Joseph Fourier, and a Ph.D. in Biotechnology in France. At Lilly, she is helping build integrated data and AI capabilities intended to improve scientific decision-making, accelerate design-make-test-analyze cycles, and support an increasingly AI-enabled biologics discovery process.
Talk
Session Abstract – PMWC 2027 Silicon Valley
Davos of Precision Medicine
PMWC 2027 Program
January 27–29, 2027 · Santa Clara Convention Center
Swipe speakers · Tap a card for sessions →
In a few words.
PMWC is indeed The Davos of Biotech
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
